Table 1.
SARS-CoV-2 variants features and the reduced infection rate in VeroE6-CD147−/− cells
| Virus name | Country of origin | Mutations (AA) | Reduced infection rate in VeroE6-CD147−/− cells | Source |
|---|---|---|---|---|
| SARS-CoV-2 | China | 73.6% | National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention | |
| Alpha | United Kingdom | HV69-70 Del, Y145 Del, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H | 51.7% | |
| Beta | South Africa | D80A, D215G, LAL242–244 Del, E484K, K417N, N501Y, D614G, A701V | 74.9% | |
| Gamma | Brazil | L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F | 55.3% | |
| Delta | India | T19R, T95I, G142D, L452R, T478K, D614G, P681R, D950N, R158del | 67.4% |